Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer

Clinical trial NCT05913570 · UNKNOWN

Trial details

NCT number: NCT05913570
Sponsor: LiuYing
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Mismatch Repair-deficient (dMMR)Microsatellite Instability-high (MSI-H)Neoadjuvant Therapy

Start date: 2023-06-20
Primary completion: 2023-12-20
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.